Virology News and Research

Latest Virology News and Research

Bio-Rad receives FDA approval for new HIV rapid test

Bio-Rad Laboratories announced today that it recently received approval from the U.S. Food and Drug Administration (FDA) for its new Multispot HIV-1/HIV-2 Rapid Test.

4 Jan 2005

AIDS breakthrough - vaccine strengthens the body’s immune system againts HIV

A Hadassah University Medical Center research team has developed a vaccine that significantly strengthens the body’s immune system against the autoimmune sequela of HIV infection, a breakthrough that could dramatically make an impact in the treatment of AIDS patients.

28 Dec 2004

Norovirus still at Christchurch Hospital

Members of the public are asked not to go to the Emergency Department at New Zealand's Christchurch hospital if they have symptoms of Norovirus – vomiting and diarrhoea.

27 Dec 2004

Theory that could help to cure diseases including cancer

An Open University science student has astonished the world of medicine with a theory that could help to cure diseases including cancer.

21 Dec 2004

New compound Viprovex could save millions

The World Health Organization (WHO) and influenza experts worldwide are concerned that the recent appearance and widespread distribution of an avian influenza virus (Influenza A/H5N1) has the potential to ignite the next pandemic and potentially kill millions.

21 Dec 2004

The burgeoning Indian AIDS epidemic

India, home to one-sixth of the human race, has an AIDS epidemic. Five million Indians are living with HIV infection. The stakes are high; the government is racing against time.

21 Dec 2004

Gene therapy effective in helping children with severe combined immunodeficiency (SCID)

A UK study in this week’s issue of THE LANCET provides further evidence that gene therapy can be effective in creating a functional immune system for infants with severe combined immunodeficiency (SCID).

20 Dec 2004

Vaccine against cervical cancer

Dutch researcher Laura Bungener has developed a vaccine against cervical cancer. Vaccinated laboratory animals no longer developed the disease and animals which had already developed a tumour, could be treated with the vaccine.

20 Dec 2004

Vaccinating mice against Lyme disease could help reduce the risk of transmission of the disease to humans

Vaccinating large populations of white-footed mice against the bacterium that causes Lyme disease could help reduce the risk of transmission of the disease to humans, says a study supported by the National Institute of Allergy and Infectious Diseases (NIAID).

14 Dec 2004

Instead of chemotherapy, drugs that influence the X protein's behavior might become an alternative cancer therapy

Identifying the link between chronic hepatitis B infection and liver cancer may one day help cancer patients sidestep the poison of chemotherapy, a Purdue University study suggests.

13 Dec 2004

Start today of human tests for a preventive vaccine against the respiratory disease SARS

Powerful research tools that speed up vaccine development have led to the start today of human tests for a preventive vaccine against the respiratory disease SARS. The disease killed hundreds of people around the world before it was brought under control in 2003 with aggressive conventional public health measures.

13 Dec 2004

First gene therapy for skin cancer

Researchers at UT Southwestern Medical Center at Dallas have successfully tested the first gene therapy for skin cancer, using a mouse model for the disease xeroderma pigmentosum, or XP.

13 Dec 2004

Targeted screening of high-risk groups for genital herpes may prevent disease transmission

Identifying asymptomatic people with genital herpes infection through targeted screening of high-risk groups may prevent disease transmission. However, widespread screening of pregnant women is unlikely to reduce the occurrence of herpes in newborns, according to an article in the January 1 issue of Clinical Infectious Diseases, now available online.

13 Dec 2004

Discovery of key immune system molecules that helps determine how effectively a person resists HIV infection

A team of researchers based partly in South Africa has identified a key set of immune system molecules that helps determine how effectively a person resists infection with human immunodeficiency virus (HIV).

8 Dec 2004

New technology will advance our understanding of role of complex sugar chains decorating the surface of cells in the body

An international consortium of scientists lead by Dr. James Paulson of The Scripps Research Institute has created a technology that will advance our understanding of the role of complex sugar chains (glycans or carbohydrates) that decorate the surface of cells in the body.

8 Dec 2004

A new study has found fatty liver disease in nearly one third of American adults in a large urban population sample

The prevalence of the disease varied significantly among ethnic groups. Hispanics had a higher prevalence than whites, while blacks had a lower prevalence than whites.

8 Dec 2004

Class of cells that arises in mammary glands during maternity has stem cell-like properties

These parity-induced mammary epithelial cells (PI-MEC) have the ability to self-renew over many generations and to differentiate into numerous cellular subtypes.

7 Dec 2004

Scientist develops way to deliver promising genetic tool into living cells

By exploiting an HIV protein that readily traverses cell membranes, Carnegie Mellon University scientists have developed a new way to introduce a gene-like molecule called a peptide nucleic acid (PNA) directly into live mammalian cells, including human embryonic stem (ES) cells.

6 Dec 2004

Episome vectors offer fresh angle to gene therapy

A European research team is seeking to overcome the early setbacks suffered by the promising new field of ‘gene therapy’ by developing a revolutionary delivery technique, known as ‘episome vectors’. This breakthrough could pave the way to treating hereditary diseases by injecting the body with healthy versions of damaged genes.

6 Dec 2004

Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning

Australian Medical Association Vice President, Dr Mukesh Haikerwal, has said the Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning.

6 Dec 2004

Virology News and Research

Latest Virology News and Research

Bio-Rad receives FDA approval for new HIV rapid test

AIDS breakthrough - vaccine strengthens the body’s immune system againts HIV

Norovirus still at Christchurch Hospital

Theory that could help to cure diseases including cancer

New compound Viprovex could save millions

The burgeoning Indian AIDS epidemic

Gene therapy effective in helping children with severe combined immunodeficiency (SCID)

Vaccine against cervical cancer

Vaccinating mice against Lyme disease could help reduce the risk of transmission of the disease to humans

Instead of chemotherapy, drugs that influence the X protein's behavior might become an alternative cancer therapy

Start today of human tests for a preventive vaccine against the respiratory disease SARS

First gene therapy for skin cancer

Targeted screening of high-risk groups for genital herpes may prevent disease transmission

Discovery of key immune system molecules that helps determine how effectively a person resists HIV infection

New technology will advance our understanding of role of complex sugar chains decorating the surface of cells in the body

A new study has found fatty liver disease in nearly one third of American adults in a large urban population sample

Class of cells that arises in mammary glands during maternity has stem cell-like properties

Scientist develops way to deliver promising genetic tool into living cells

Episome vectors offer fresh angle to gene therapy

Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation